Profile: Inbios International, Inc. is a medical diagnostic company which specializes in developing, manufacturing and marketing medical diagnostic tests for the detection of infectious diseases. We have two FDA cleared products. One is Kalazar Detect™ rapid test for visceral leishmaniasis and the other is the west nile Detect™ igm capture ELISA for the detection of the west nile virus. Our products are JE Detect™ an ELISA test for Japanese encephalitis, Active TB Detect™ and a rapid & ELISA test for T. cruzi infection (Chagas Disease).
The company was founded in 1996, has revenues of USD 10-25 Million, has ~20 employees and is ISO certified.
FDA Registration Number: 3032562
4 Products/Services (Click for related suppliers)
|
• Analyte Specific Reagents, Asr Reagents (FDA Code: MVU / 864.4020) Analyte specific reagents (ASR's) are antibodies, both polyclonal and monoclonal, specific receptor proteins, ligands, nucleic acid sequences, and similar reagents which, through specific binding or chemical reaction with substances in a specimen, are intended for use in a diagnostic application for identification and quantification of an individual chemical substance or ligand in biological specimens. ASR's that otherwise fall within this definition are not within the scope of subpart E of this part when they are sold to: |
• Leishmanii Serological Reagent (FDA Code: LOO / 866.3870) |
• West Nile Virus (WNV) Test Kits |
• West Nile Virus Antibody Elisa (FDA Code: NOP / 866.3940) West Nile virus serological reagents are devices that consist of antigens and antisera for the detection of anti-West Nile virus IgM antibodies, in human serum, from individuals who have signs and symptoms consistent with viral meningitis/encephalitis. The detection aids in the clinical laboratory diagnosis of viral meningitis/encephalitis caused by West Nile virus. |